Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
---|---|---|---|---|---|---|
2021 | Economic impact of abrocitinib monotherapy and combination therapy in patients with moderate-to-severe atopic dermatitis: Results from JADE MONO-2 and JADE COMPARE | Gooderham, Melinda J; CHIA-YU CHU ; Rojo, Ricardo; Valdez, Hernan; Biswas, Pinaki; Cameron, Michael C; et al., | JAAD international | 9 | 0 |